FDA warns against unregistered eye drop, orders seizure from stores
April 11, 2014 7:48pm
The Food and Drug Administration on Friday warned the public against an unregistered eye drop product for a range of conditions from astigmatism to "blurry 'computer' vision."
In Advisory 2014-029, the FDA identified the product as CMD Eye Drop, which it said is being sold at P120 per 15-ml bottle and sold by refill in some provinces.
"The FDA warns the public that the use of unregistered eye drops presents safety risks and adverse health consequences. Since eye drops are to be applied directly to the eye area, the preparation of these solutions requires special consideration and should only be dispensed in special containers," it said.
The FDA also warned that "the use of unregistered eye drops...may result in inflammation, irritation. infection of the eye or loss of vision."
continue to read here
In Advisory 2014-029, the FDA identified the product as CMD Eye Drop, which it said is being sold at P120 per 15-ml bottle and sold by refill in some provinces.
"The FDA warns the public that the use of unregistered eye drops presents safety risks and adverse health consequences. Since eye drops are to be applied directly to the eye area, the preparation of these solutions requires special consideration and should only be dispensed in special containers," it said.
The FDA also warned that "the use of unregistered eye drops...may result in inflammation, irritation. infection of the eye or loss of vision."
continue to read here
No comments:
Post a Comment